After a significant update in 2014, some House members want to adjust the tropical disease priority review voucher program again in the 21st Century Cures bill to further increase its flexibility and popularity.
FDA would be required to create and publish a method for adding diseases to the list of those eligible for the voucher program as well as regularly update it, according...